Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 134241, "name": "Jagsonpal Pharma", "stock_name": "Jagsonpal Pharma", "full_name": "Jagsonpal Pharmaceuticals Ltd", "name_url": "stocks-analysis/jagsonpal-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "206.05", "chg": -3.25, "chgp": "-1.55%", "dir": -1, "prev_price": "209.30", "mcapval": "1,385.00 Cr", "mcap": "Micro Cap", "scripcode": 507789, "symbol": "JAGSNPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE048B01035", "curr_date": "May 25", "curr_time": "", "bse_nse_vol": "1.47 lacs", "exc_status": "Active", "traded_date": "May 25, 2026", "traded_date_str": "2026 05 25", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jagsonpal-pharma-134241-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Jagsonpal Pharmaceuticals Gains 1.36%: Technical Momentum Shift Amid Mixed Fundamentals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-gains-136-technical-momentum-shift-amid-mixed-fundamentals-4009563", "imagepath": "", "date": "2026-05-24 17:00:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>18 May:</strong> Stock opens at Rs.200.15, down 3.08% amid broader market weakness</p>\n <p><strong>19 May:</strong> Mojo Grade upgraded to Sell from Strong Sell on technical improvements</p>\n <p><strong>21 May:</strong> Sharp price jump to Rs.211.70 (+5.64%) signalling renewed buying interest</p>\n <p><strong>22 May:</strong> Week closes at Rs.209.30, down slightly from prior day but up 1.36% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.200.15</div></div>\n <div cla..." }, { "title": "Jagsonpal Pharmaceuticals Ltd Shows Signs of Technical Momentum Shift Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-shows-signs-of-technical-momentum-shift-amid-mixed-indicators-4004139", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_4004139.png", "date": "2026-05-22 08:00:11", "description": "Jagsonpal Pharmaceuticals Ltd has exhibited a notable shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, supported by a blend of technical indicators that present a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Jagsonpal Pharmaceuticals Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3998252", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_mojoScore_3998252.png", "date": "2026-05-19 08:15:30", "description": "Jagsonpal Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook amid ongoing financial headwinds. While the company’s quarterly results remain under pressure, improvements in technical indicators and a stabilising price trend have prompted a reassessment of its market stance." }, { "title": "Jagsonpal Pharmaceuticals Falls 5.23%: Mixed Technicals and Downgrade Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-falls-523-mixed-technicals-and-downgrade-shape-weekly-trend-3995643", "imagepath": "", "date": "2026-05-17 16:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Stock opens at ₹210.20, down 3.53% amid broad market weakness</p>\n <p><strong>12 May:</strong> Technical momentum shifts to mildly bearish; stock closes at ₹212.65 (+1.17%)</p>\n <p><strong>13 May:</strong> Downgrade to Strong Sell rating announced following weak financials</p>\n <p><strong>14 May:</strong> Technical trend shifts to sideways; stock closes at ₹210.05 (-1.22%)</p>\n <p><strong>15 May:</strong> Week closes at ₹206.50 (-0.55%) amid subdued volume</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">..." }, { "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-3990280", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_3990280.png", "date": "2026-05-14 08:00:13", "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day decline of 1.22%, the stock’s longer-term performance continues to outpace the Sensex, though technical indicators suggest caution for investors navigating this micro-cap pharmaceutical player." }, { "title": "Jagsonpal Pharmaceuticals Downgraded to Strong Sell Amid Mixed Technicals and Weak Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-downgraded-to-strong-sell-amid-mixed-technicals-and-weak-financials-3988810", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_mojoScore_3988810.png", "date": "2026-05-13 08:07:12", "description": "Jagsonpal Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating, reflecting deteriorating technical indicators and disappointing recent financial results. The micro-cap pharmaceutical company’s Mojo Score has fallen to 27.0, signalling heightened caution for investors amid a combination of weak price momentum, subdued valuation appeal, and faltering financial trends." }, { "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-3986229", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_technicaldot_3986229.png", "date": "2026-05-12 08:00:26", "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflecting a complex technical landscape for this micro-cap player in the Pharmaceuticals & Biotechnology sector." }, { "title": "Jagsonpal Pharmaceuticals Gains 2.66%: 3 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-gains-266-3-key-factors-driving-the-week-3984314", "imagepath": "", "date": "2026-05-10 16:01:02", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>4 May:</strong> Week opens at Rs.212.25</p>\n <p><strong>5 May:</strong> Technical momentum shifts amid mixed indicator signals</p>\n <p><strong>7 May:</strong> Mojo Grade upgraded from Strong Sell to Sell</p>\n <p><strong>8 May:</strong> Stock closes at Rs.217.90, up 2.13% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.212.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.217.90</div><div class=\"stat-change positiv..." }, { "title": "Jagsonpal Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-upgraded-to-sell-on-technical-improvements-despite-financial-challenges-3980835", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JagsonpalPharma_mojoScore_3980835.png", "date": "2026-05-08 08:05:00", "description": "Jagsonpal Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing financial headwinds. The company’s quality, valuation, financial trend, and technical parameters have been reassessed, reflecting a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector." } ], "total": 258, "sid": "134241", "stock_news_url": "https://www.marketsmojo.com/news/jagsonpal-pharmaceuticals-134241" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director", "datetime": "18-May-2026", "details": "Resignation of an Independent Director.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "07-May-2026", "details": "Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company", "source": "BSE" }, { "caption": "Submission Of Letter Of Offer For Buy-Back Upto 1600000 Equity Shares", "datetime": "06-May-2026", "details": "Submission of Letter of Offer for Buy- Back upto 1600000 Equity Shares at price of INR-250/- per share amounting to INR-400000000/-", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>125%</strong> dividend, ex-date: 12 Sep 25", "dt": "2025-09-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25", "dt": "2025-01-08", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

11 May: Stock opens at ₹210.20, down 3.53% amid broad market weakness

12 May: Technical momentum shifts to mildly bearish; stock closes at ₹212.65 (+1.17%)

13 May: Downgrade to Strong Sell rating announced following weak financials

14 May: Technical trend shifts to sideways; stock closes at ₹210.05 (-1.22%)

15 May: Week closes at ₹206.50 (-0.55%) amid subdued volume

...

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals

2026-05-14 08:00:13

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day decline of 1.22%, the stock’s longer-term performance continues to outpace the Sensex, though technical indicators suggest caution for investors navigating this micro-cap pharmaceutical player.

Read full news article

Jagsonpal Pharmaceuticals Downgraded to Strong Sell Amid Mixed Technicals and Weak Financials

2026-05-13 08:07:12

Jagsonpal Pharmaceuticals Ltd has been downgraded from a Sell to a Strong Sell rating, reflecting deteriorating technical indicators and disappointing recent financial results. The micro-cap pharmaceutical company’s Mojo Score has fallen to 27.0, signalling heightened caution for investors amid a combination of weak price momentum, subdued valuation appeal, and faltering financial trends.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals

2026-05-12 08:00:26

Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, monthly signals suggest caution, reflecting a complex technical landscape for this micro-cap player in the Pharmaceuticals & Biotechnology sector.

Read full news article

Jagsonpal Pharmaceuticals Gains 2.66%: 3 Key Factors Driving the Week

2026-05-10 16:01:02

Key Events This Week

4 May: Week opens at Rs.212.25

5 May: Technical momentum shifts amid mixed indicator signals

7 May: Mojo Grade upgraded from Strong Sell to Sell

8 May: Stock closes at Rs.217.90, up 2.13% on the day

Read full news article

Jagsonpal Pharmaceuticals Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges

2026-05-08 08:05:00

Jagsonpal Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing financial headwinds. The company’s quality, valuation, financial trend, and technical parameters have been reassessed, reflecting a nuanced outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News